IMBRUVICA vs LEMTRADA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. IMBRUVICA and LEMTRADA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IMBRUVICA	LEMTRADA
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	IBRUTINIB	ALEMTUZUMAB
Manufacturer	Pharmacyclics LLC	Genzyme
Dosage forms	Capsule, Suspension, Tablet	Injectable
Drug class	—	Cd52-Directed Cytolytic Antibody
Boxed warning	None	Boxed warning
Treats	Waldenstrom Macroglobulinemia, B-Cell Chronic Lymphocytic Leukemia, B-Cell Lymphoma	B-Cell Chronic Lymphocytic Leukemia

imbruvica lemtrada

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

IBRUTINIB

ALEMTUZUMAB

Manufacturer

Pharmacyclics LLC

Genzyme

Dosage forms

Capsule, Suspension, Tablet

Injectable

Drug class

—

Cd52-Directed Cytolytic Antibody

Boxed warning

None

Boxed warning

Treats

Waldenstrom Macroglobulinemia, B-Cell Chronic Lymphocytic Leukemia, B-Cell Lymphoma

B-Cell Chronic Lymphocytic Leukemia

Frequently asked questions

What is the difference between Imbruvica and Lemtrada?

Imbruvica contains Ibrutinib, while Lemtrada contains Alemtuzumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.